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The Metabolic Syndrome increases the risk for atherosclerotic cardiovascular disease and type 2 Diabetes Mellitus. Increased
fructose consumption and/or mineral deficiency have been associated withMetabolic Syndrome development.This study aimed to
investigate the effects of 8 weeks consumption of a hypersaline sodium-rich naturally sparkling mineral water on 10% fructose-fed
Sprague-Dawley rats (Metabolic Syndrome animalmodel).The ingestion of themineral water (rich in sodiumbicarbonate andwith
higher potassium, calcium, and magnesium content than the tap water used as control) reduced/prevented not only the fructose-
induced increase of heart rate, plasma triacylglycerols, insulin and leptin levels, hepatic catalase activity, and organ weight to body
weight ratios (for liver and both kidneys) but also the decrease of hepatic glutathione peroxidase activity and oxidized glutathione
content. This mineral-rich water seems to have potential to prevent Metabolic Syndrome induction by fructose. We hypothesize
that its regular intake in the context of modern diets, which have a general acidic character interfering with mineral homeostasis
and are poor in micronutrients, namely potassium, calcium, and magnesium, could add surplus value and attenuate imbalances,
thus contributing to metabolic and redox health and, consequently, decreasing the risk for atherosclerotic cardiovascular disease.
1. Introduction
TheMetabolic Syndrome (MS) consists of multiple and inter-
related risk factors of metabolic origin that appear to directly
promote the development of atherosclerotic cardiovascular
disease. The MS strongly associates with type 2 Diabetes
Mellitus, or the risk for this condition. Although the exact
etiology of the MS still remains unclear, it is known to
involve complex interactions between genetic,metabolic, and
environmental factors, where diet is of central importance
[1–3].
There has been a substantial increase in fructose con-
sumption, in the last decades, which has been associated with
some adverse metabolic changes similar to those observed
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in the MS [4–7]. On the other hand, minerals like potas-
sium, calcium, and magnesium, proposed as protective
against the MS, are generally deficient in MS-inducing diets
[3, 8–10].
Natural mineral waters are waters of underground origin,
protected from contamination and microbiologically whole-
some.They are characterized by their purity at source, content
in minerals, trace elements, and other constituents as well
as by favorable effects on human health [11]. Additionally,
bioavailability ofminerals fromnaturalmineral waters is high
[12–14].
The fructose-fed rat is an interesting and well-validated
animal model of diet-induced MS (predominantly acquired
MS model) that is commonly used in MS research [15].
Different rat strains with distinct fructose ingestion protocols
are reported in the literature and, in all cases, fructose has
been observed to induce MS features such as moderate
hypertension, glucose intolerance, hyperinsulinemia, insulin
resistance, dyslipidemia (hypertriglyceridemia, hypercholes-
terolemia), altered cytokine and adipokine status (altered
tumor necrosis factor-alpha (TNF-𝛼) and leptin levels, e.g.),
decreased melatonin production, and/or increased body fat
and/or body weight [15–20].
Both in humans and rats, a strong association has been
found between MS and oxidative stress [21] and fructose-
feeding associates with modification of the hepatic redox
status [16, 22–24].
Beneficial effects of acute or chronic natural mineral-rich
waters ingestion on blood pressure (BP) [25–27], metabolic
profile (plasma insulin sensitivity [28], fasting serum glucose
concentration [29], and fasting serum lipid profile [25, 29]),
and plasma oxidative stress markers (reactive oxygen species
[30], lipid and protein oxidation product levels, total antioxi-
dant capacity, and total thiol levels [31]) have been published,
but, to our knowledge, not in MS individuals or animal
models. The natural mineral waters tested are rich, albeit in
different proportions, in bicarbonate, calcium, magnesium,
potassium, and/or sodium.
We aimed to investigate the possible beneficial effect of
natural mineral-rich water on MS induction by fructose-
feeding. In the present work, Sprague-Dawley rats (SDR)
were fed with 10% fructose in natural mineral-rich water
(Pedras Salgadas) for 8 weeks and compared to animals fed
10% fructose in tap water. The natural mineral-rich water
tested has high total mineralization content (2855mg/L),
being mainly rich in sodium and bicarbonate and with
higher potassium, calcium, and magnesium content than tap
water.
2. Material and Methods
2.1. Animals and Treatments. The study was carried out in
21 adult male CD SDR (388–483 g), from Charles River Lab-
oratories (Chatillon/Chalaronne, France). Telemetry trans-
mitters (TA11PA-C40, Data Sciences International (DSI), St.
Paul,MN,USA)were implanted in the abdominal cavity, with
the catheter in the abdominal aorta, by Charles River. Rats
were shipped on the 5th day after surgery. Upon arrival, rats
were individually housed, in an enriched environment, and
maintained on a daily photoperiod of 12 h lighting schedule
(20–22∘C) with free access to standard laboratory pellet food
(2014 Teklad Global 14% Protein Rodent Maintenance Diet
from Harlan Interfauna Iberica SA, Barcelona, Spain) and
tap water. Acclimatization took place for 10 days before
starting the experimental protocol, which was authorized
by the Veterinary National Department of the Ministry
of Agriculture, Rural Development and Fisheries. During
acclimatization, rats spent gradually increasing periods of
time inside metabolic cages. The handling and care of the
animals were conducted in conformity with the European
Community Council guidelines for the use of experimental
animals (86/609/EEC) and Act 129/92.
Animals were randomly divided into 3 groups (7 animals
each) with free access to different drinking solutions: (a)
tap water (CONT), (b) 10% fructose in tap water (FRUCT),
or (c) 10% fructose in natural mineral-rich water (FRUCT-
MIN). All experimental groups were fed ad libitum with
the standard laboratory chow diet mentioned above (20% of
energy derived from protein, 13% from fat, and 67% from
carbohydrate). The dietary manipulation lasted 8 weeks. A
3-week pretreatment period with the natural mineral-rich
water was performed to the FRUCTMIN group (while the
other rats were drinking tap water) to allow adjustment to
water flavor and sparkles. This period of time induced no
change in the pattern of food intake or increase of animals
body weight (data not shown; all animals weighed 475–
597 g at the beginning of the dietary manipulation with
fructose). Body weight and food and fluid ingestion values
were registered weekly, from week 0 to week 7 or 8 (as shown
in Figures 1(a)–1(c), resp.). On week 0 these parameters were
evaluated on the same day, which occurred 24 to 48 h after
starting the dietary manipulation, and then on every one
week after the first measurement. Each week, from week 0 to
7, all animals spent 24 h inside metabolic cages for evaluation
of food and fluid consumption as well as for urine collection
(the latter at 0, 2, 4, and 6 weeks). At each occasion, the
three groups of rats were represented, with an equal number
of animals per group. Total energy ingestion was calculated
by multiplying food and fluid ingestion values by the corre-
sponding reference energy values and then adding these two
results.
The chemical characteristics of tap and natural mineral-
rich waters are given in Table 1. The latter is classified
as a hypersaline sodium-rich naturally sparkling mineral
water, in conformity with the European Community Council
guidelines for natural mineral waters (2009/54/EEC), and
was kindly provided by Unicer Bebidas, SA (Lec¸a do Balio,
Matosinhos, Portugal).
2.2. Assessment of Blood Pressure and Heart Rate. Dataquest
ART 4.1 Silver telemetry system (DSI) with RCP-1 receivers
(and APR-1 for ambient pressure reference) was used for
telemetric measurement of BP (mm Hg) and heart rate (HR;
beats/min) in the animal cage. Dataquest ART acquisition
software (DSI) was used to monitor all rats, for 8 weeks. Sam-
pling was performed everymin and setting segment duration
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Figure 1: (a) Body weight (g; 𝑛 = 7; ∗𝑃 < 0.05 CONT versus FRUCTMIN (Δ body weight (g; 𝑛 = 7), between weeks 8 and 0 in the inset;
#
𝑃 < 0.01 FRUCT and FRUCTMIN versus CONT)), (b) food ingestion (g; 𝑛 = 7; ∗𝑃 < 0.05 CONT versus FRUCTMIN, and (c) fluid
ingestion evolution (mL; 𝑛 = 7; +𝑃 < 0.05 CONT versus FRUCT and FRUCTMIN; #𝑃 < 0.001 CONT versus FRUCT and FRUCTMIN;
$
𝑃 < 0.05 CONT versus FRUCT and 𝑃 < 0.01 CONT versus FRUCTMIN; $$𝑃 < 0.01 CONT versus FRUCT and 𝑃 < 0.05 CONT versus
FRUCTMIN; ∗∗𝑃 < 0.01 CONT versus FRUCTMIN), during the dietary intervention. Results were expressed as mean ± standard error of
the mean. CONT: control; FRUCT: 10% fructose in tap water; FRUCTMIN: 10% fructose in natural mineral-rich water.
at 20 s; 3 different animals (one from each experimental
group) were evaluated per day from 4:00 p.m. to 8:00 a.m.,
seven days per week. BP values were not included/considered
if pulse pressure (the difference between systolic and diastolic
BP) was below 20mm Hg and HR values were not used if
pulse pressure values were lower than 10mm Hg [32]. Data
were exported from Dataquest ART 4.0 analysis program
(DSI) toMicrosoftExcel 2010 (Redmond,WA,USA) and then
subjected to statistical analysis.
2.3. Collection of Samples. All chemical substances used in all
the experiments were of analytical grade.
At the end of the dietary intervention, animals were
deeply anesthetized with sodium pentobarbital (80mg/kg of
body weight) and blood was collected from the left ventricle
into heparinized syringes. Then, rats were transcardially
perfused with ice-cold isotonic sodium chloride solution.
After perfusion, liver, heart, kidneys, and epididymal adipose
tissuewere rapidly removed from the thoracic and abdominal
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Table 1: Chemical characteristics of tap and natural mineral waters.
Characteristics Tap water
Hypersaline sodium-rich
naturally sparkling mineral
water—Pedras Salgadas
Total mineralization (mg/L) 148–151 2855
pH 6.5–9.0 6.16
Sodium (mg/L) 200 591
Calcium (mg/L) 30.5–40.2 92.5
Magnesium (mg/L) 3.6–9.2 26.2
Potassium (mg/L) 2.6 29.9
Copper (mg/L) 2 0.0013
Zinc (𝜇g/L) ∗ 1.1
Selenium (𝜇g/L) 10 <2.0
Bicarbonate (mg/L) ∗ 2013
Chloride (mg/L) 250 30.8
Sulphate (mg/L) 250 6.4
∗: no need for control (Portuguese Act 306/2007, from 27th of August).
cavities, washed in cold saline solution, placed in quali-
tative filter paper for excess liquid removal, and weighed.
The liver was cut into several fragments that were immersed
in liquid nitrogen and stored at −80∘C, until further process-
ing.
2.4. Assessment of Plasma Biochemical, Metabolic, Hormo-
nal, and Inflammatory Markers and Assessment of Urinary
Creatinine and Sodium. Plasma concentrations of glucose,
triacylglycerols, total cholesterol, HDL-cholesterol, LDL-
cholesterol, C-reactive protein (CRP), glutamic-oxaloacetic
transaminase (GOT), glutamic-pyruvic transaminase (GPT),
total bilirubin, uric acid, urea, creatinine, total proteins,
albumin, ferritin, sodium, potassium, chloride, magnesium,
calcium, and phosphorus were determined. Urinary creati-
nine and sodium excretions were also evaluated. All these
quantifications were made at the Clinical Pathology Unit
of Sa˜o Joa˜o Hospital Centre, EPE, Porto, Portugal, using
standardized methods for human sample routine hospital
measurements.
Plasma levels of insulin (Mercodia AB, 10-1137-01 (Uppsa-
la, Sweden)), adiponectin (Invitrogen Corporation, KRP0041
(Camarillo, CA, USA)), aldosterone (Uscn Life Science Inc.,
E0911Ra (Wuhan, China)), substance P (R&D Systems Inc.,
KGE007/SKGE007/PKGE007 (Minneapolis, MN, USA)),
interleukin-6 (IL-6; Cusabio Biotech Co. Ltd., CSB-E04640r
(Wuhan, China)), and TNF-𝛼 (Cusabio, CSB-E11987r) were
evaluated according to the manufacturers’ instructions from
the specific ELISA kits. Plasma concentrations of melatonin
(RSH69K), nuclear factor kappa-B ligand (RANKL; RBN-
31 K-1RANKL), leptin, and osteoprotegerin (OPG; RBN1-
31 K) were measured with a Luminex 200 analyzer (Luminex
Corporation, Austin, TX, USA) according to protocols (MIL-
LIPLEX MAP kits) of Millipore Corporation (Billerica, MA,
USA). Raw data (mean fluorescence intensity) were analyzed
using ISTM 2.3 software (Luminex Corporation).
2.5. Assessment of Hepatic Redox State Markers. Oxidative
damage to lipids, proteins, and DNA was evaluated by mea-
suring thiobarbituric acid-reactive substances (viz., malondi-
aldehyde (MDA)), carbonyls, and 8-hydroxy-2󸀠-de-oxygua-
nosine (8-OHdG) levels, respectively. Catalase, total superox-
ide dismutase (SOD), glutathione-S-transferase (GST), glu-
tathione-peroxidase (GPx), and glutathione-reductase (GR)
activities were quantified. Reduced (GSH) and oxidized
(GSSG) glutathione concentrations were also determined. All
these techniques were performed as described by Assunc¸a˜o
et al. [33], except for the use of Bradford method for protein
quantification and the use of a kit for 8-OHdG quantification
(theDNA extraction kit (V-gene) was purchased fromBioron
International (Ludwigshafen, Germany) and the 8-OHdG
kit from Japan Institute for the Control of Aging (Haruoka,
Fukuroi, Shizuoka, Japan)).
2.5.1. Protein Extraction and Sirtuin 3 Protein Expression
by Western Blot. Liver tissue samples (300–450mg) were
homogenized with a Teflon-glass homogenizer in an equal
volume of protein extraction buffer (50mM Tris-base,
150mM NaCl, pH 7.4, 1% Triton X-100, 0.5% sodium deoxy-
cholate, 0.1% sodium dodecyl sulfate (SDS), 1mM EDTA,
tablets of protease inhibitors, and phosphatase inhibitors
(100mM sodium fluoride and 10mM sodium orthovana-
date)), with subsequent agitation for 30min at 4∘C. Then,
each sample was centrifuged, at 13 000 g for 20min at 4∘C,
and the protein solution under the lipid layer was collected
and kept at −80∘C, until further analysis.
Proteins were quantified by using the bicinchoninic acid
protein assay kit (Pierce, Rockford, IL, USA). Proteins were
dissolved (1 : 1) in loading buffer (50mM Tris-HCl, pH 6.8,
100mM dithiothreitol, 2% SDS, 0.01% bromophenol blue
and 10% glycerol) and denatured, for 5min at 95∘C. Then,
40 𝜇g of each sample was loaded per well, separated by elec-
trophoresis in a 12% SDS polyacrylamide gel, and transferred
to a nitrocellulose membrane (Hybond C-Extra, Amersham,
GE Healthcare, Buckinghamshire, UK). The membrane was
blocked in Tris-base-buffered saline with 0.1% Tween 20
(v/v) (TBST) containing 5% bovine serum albumin (w/v)
and incubated overnight with the primary antibody against
sirtuin 3 (Sirt3; Cell Signaling Technology Inc., Danvers, MA,
USA) diluted 1 : 1500 in TBST, with gentle agitation, at 4∘C.
Then, the membrane was washed in TBST and incubated
with donkey anti-rabbit polyclonal antibody conjugated to
horseradish peroxidase (Santa Cruz Biotechnology Inc., Hei-
delberg, Germany), diluted 1 : 5000 in TBST, for 1 h at room
temperature. Detection was performed with an enhanced
chemiluminescence reagent (Amersham, GE Healthcare,
Buckinghamshire, UK). Band intensity was determined using
Image Lab software (version 4.0.1; Bio-Rad Laboratories,
Hercules, CA, USA) and normalized for 𝛽-actin expression
(1 : 1000 and 1 : 2000 for primary and secondary antibod-
ies (Santa Cruz Biotechnology Inc., Heidelberg, Germany),
respectively, diluted in 5% (w/v) of nonfat dry powderedmilk
Sveltesse (Nestle´ Portugal SA, Linda-a-Velha, Portugal) in
TBST).
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2.6. Liver Magnesium and Calcium Content. Liver magne-
sium and calcium content were measured by inductively
coupled plasma optical emission spectrometry (ICP-OES;
ActivaM, JobinYvon, Horiba Scientific, Edison, NJ, USA), at
285.213 nm and 422.673 nm, respectively, according to ISO
11885 (water quality—determination of selected elements by
ICP-OES (https://www.astandis.at/shopV5/Preview.action;js
essionid=CF7234FBAC2BCFDD35A4593A11BD4700?previe
w=&dokkey=347061&selectedLocale=en)), after microwave
oven (Mars 5, CEM Corporation, Matthews, NC, USA)
assisted acid digestion of liver fragments according to EPA
3052 (microwave assisted acid digestion of siliceous and
organically basedmatrices (http://www.epa.gov/osw/hazard/
testmethods/sw846/pdfs/3052.pdf)).
2.7. Statistical Methods. The significance of differences of
each week, cross-sectional statistical analysis, among groups
regarding systolic and diastolic BP, HR, body weight, food
and fluid ingestions, urine volume, urinary sodium and
creatinine excretions, total energy ingestion, and percentage
energy supplied by fluid/total energy ingestion was evaluated
using ANOVA followed by Bonferroni’s multiple compari-
son test or by Kruskal-Wallis followed by Dunn’s multiple
comparison test, according to their distribution. These sta-
tistical methods were also used for evaluation of significance
of differences among groups regarding organ weight/body
weight, hepatic oxidative stress markers, andmineral content
as well as plasma biochemical, metabolic, hormonal, and
inflammatory data, at the end of the dietary intervention.The
association between the outcomes (systolic and diastolic BP,
HR, body weight, food and fluid ingestions, urine volume,
urinary sodium and creatinine excretions, total energy inges-
tion, and percentage energy supplied by fluid/total energy
ingestion) and the interaction of dietary intervention with
time evolution (evaluated in weeks), longitudinal statistical
analysis, was measured with the interaction terms (𝛽), which
were estimated by mixed effects model with random effect in
the intercept.The area under the curve (AUC) was calculated
through linear interpolation using the composite trapezoid
rule [34].
Statistical analysis was performed using R: A language
and environment for statistical computing [34], GraphPad
Prism software (version 6.00; La Jolla, CA, USA), or IBM
SPSS Statistics software (version 20.0; Armonk, NY, USA).
Values were presented as mean ± standard error of the mean
and differences considered significant for 𝑃 < 0.05.
3. Results
3.1. Parameters Evaluated over the 8-Week Period of
Dietary Intervention
3.1.1. Body Weight, Food and Fluid Ingestions. In general,
on each separate week (week by week), body weight (Fig-
ure 1(a)) and food ingestion (Figure 1(b)) revealed simi-
lar values for the 3 animal groups. With time (over the
dietary intervention period), a significantly higher and
similar increase of body weight for both fructose groups
versus CONT group was observed (see Supplementary
Table 1 in the supplementary material available online
at http://dx.doi.org/10.1155/2014/384583 and inset in Fig-
ure 1(a)). With time FRUCTMIN rats decreased food inges-
tion significantly more than CONT rats and showed a
trend towards a higher decrease with time than FRUCT
rats (Supplementary Table 1). Week by week, fluid inges-
tion showed significantly higher values for both fructose-
fed groups versus CONT group, without any significant
difference between FRUCT and FRUCTMIN (Figure 1(c)),
which was in accordance with AUC values (Supplementary
Table 2). Fluid ingestion increased significantly for FRUCT-
MIN versus CONT and FRUCT with time (Supplementary
Table 1).
3.1.2. Energy Supplied by Fluid to Total Energy Ingestion Ratio
and Total Energy Ingestion. Week by week, no differences
were observed for fructose ingestion (either from fluid
ingestion or from both food and fluid ingestions (data not
shown)) neither for percentage energy supplied by fluid/total
energy ingestion between the two intervention groups (the
latter being in accordance with AUC values; Figure 2(a) and
Supplementary Table 2), in which there was a substantial
proportion of energy ingested from fluid (48–72% of total
energy ingestion; Figure 2(a)). Total energy ingestionwas sig-
nificantly higher everyweek of the protocol for both fructose-
fed groups versus CONT group, without any significant
difference between FRUCT and FRUCTMIN (Figure 2(b)),
which was in accordance with AUC (Supplementary Table 2)
and body weight (Figure 1(a)) results. Total energy ingestion
decreased similarly with time for all groups (Supplementary
Table 3; data not shown for controls).
3.1.3. Urine Volume and Urinary Sodium and Creatinine
Excretions. With time, urine volume was significantly higher
in FRUCTMIN versus CONT and FRUCT (Supplementary
Table 4). Week by week, urinary sodium excretion values
were expected when taking into consideration the sodium
content of tap and natural mineral-rich waters: FRUCTMIN
group had significantly higher values than the other two
animal groups, without any significant difference between
FRUCT and CONT (Figure 3(b)), which also agreed with
AUC values (Supplementary Table 2).
3.1.4. Blood Pressure and Heart Rate. Between weeks 1 and
5, FRUCT rats had a significantly higher HR than CONT rats
(Figure 4(b)). Interestingly, both systolic and diastolic BP and
HR evolution over time seemed to be protected from fructose
effects by the natural mineral-rich water until approximately
half of the dietary intervention period (Figures 4(a)-4(b),
resp.). A significant increase of systolic BP with time for
both fructose groups versus CONT group was observed
(Supplementary Table 5). Diastolic BP in FRUCTMIN group
showed a tendency to increase with time versus CONT
group (Supplementary Table 5). A significant increase of
HR with time for FRUCTMIN versus CONT was observed
(Supplementary Table 5).
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Figure 2: (a) Percentage energy supplied by fluid/total energy ingestion (𝑛 = 7) and (b) total energy ingestion evolution (kcal; 𝑛 = 7;
+
𝑃 < 0.05 CONT versus FRUCT and FRUCTMIN; ++𝑃 < 0.01 CONT versus FRUCT and FRUCTMIN; $𝑃 < 0.001 CONT versus FRUCT
and FRUCTMIN; +$𝑃 < 0.05 CONT versus FRUCT and 𝑃 < 0.001 CONT versus FRUCTMIN; ++$𝑃 < 0.01 CONT versus FRUCT and
𝑃 < 0.001 CONT versus FRUCTMIN), during the dietary intervention. Results were expressed as mean ± standard error of the mean.
CONT: control; FRUCT: 10% fructose in tap water; FRUCTMIN: 10% fructose in natural mineral-rich water.
3.2. Organ Weight to Body Weight Ratios. Liver and both
kidneysweight to bodyweight ratioswere significantly higher
in FRUCT versus CONT (Figures 5(a), 5(c), and 5(d), resp.).
Additionally, the liver showed a strong trend to an increase
in FRUCTMIN versus CONT (𝑃 = 0.053) and a significant
increase in FRUCT versus FRUCTMIN (Figure 5(a)). Natural
mineral-rich water ingestion prevented fructose effects on
liver and both kidneys weight to body weight ratios.
Epididymal adipose tissue to body weight ratio was
slightly and similarly higher in both fructose-fed animal
groups versus CONT group (Figure 5(b)). No differences
were found among groups regarding heart weight/body
weight (data not shown).
3.3. PlasmaHormonal andMetabolic Profiles. Triacylglycerol
levels significantly increased in FRUCT versus CONT and
a tendency to an increase in FRUCTMIN versus CONT
(𝑃 = 0.080) was observed (Figure 6(b)). Insulin significantly
increased (Figure 6(c)) and leptin variation followed the same
pattern in FRUCT versus CONT (𝑃 = 0.057) (Figure 6(d)).
Insulin sensitivity index was also calculated [35] and a strong
tendency to a decreasewas observed in FRUCTversusCONT
(P and global 𝑃 = 0.055; 0.247 × 106 ± 0.032 × 106, 0.137 ×
10
6
± 0.009 × 10
6, and 0.211 × 106 ± 0.030 × 106 for CONT,
FRUCT, and FRUCTMIN, resp.). Glucose (Figure 6(a)) and
aldosterone (Figure 6(e)) seemed to increase and melatonin
(Figure 6(f)) seemed to decrease in FRUCT versus CONT.
Natural mineral-rich water ingestion appeared to counteract
these fructose-induced metabolic and hormonal effects. No
variations were observed for adiponectin levels (data not
shown).
3.4. Plasma Biochemical and Inflammatory Profiles. Urea
(Table 2) and magnesium (Table 3) levels significantly
decreased in the two fructose-fed groups versus the CONT
group. Total proteins and albumin levels significantly in-
creased in both groups of fructose-fed animals versus CONT
group (except for total proteins in FRUCTMIN versus
CONT where a strong tendency was observed) (Table 2).
TNF-𝛼 and IL-6 levels seemed to increase and OPG to
RANKL ratio seemed to decrease in FRUCT versus CONT
(Table 2), with the natural mineral-rich water improv-
ing these parameters. CRP and substance P levels slightly
increased in FRUCTMIN versus the other two animal
groups (Table 2). The replacement of food by fructose
solution as an energy source could explain the similar
decreases in plasma urea, magnesium, GOT, GPT, ferritin,
and uric acid levels in both fructose-fed SDR groups ver-
sus CONT group (although significantly only for some
parameters).
3.5. Hepatic Redox Status Markers. Catalase and SOD activi-
ties and GSH to GSSG ratio increased (Figures 7(a), 7(b), and
7(e), resp.) and GPx activity, GSSG level and Sirt3 protein
expression decreased (Figures 7(c), 7(d), and 7(f), resp.) in
FRUCT versus CONT (significantly for catalase, GPx, and
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Table 2: Plasma biochemical and inflammatory marker levels, at the end of the dietary intervention.
CONT FRUCT FRUCTMIN Global P
[P between two groups]Mean (SEM) Mean (SEM) Mean (SEM)
GOT (U/L),
𝑛 = 7
105.14 (13.062) 82.14 (11.066) 84.71 (7.383) 0.279
GPT (U/L),
𝑛 = 7
50.86 (8.681) 38.57 (1.192) 36.57 (2.626) 0.146
Total bilirubin (mg/L),
n = 5–7 2.00 (0.0655) 1.90 (0.0447) 2.07 (0.127) 0.481
Uric acid (mg/L),
n = 5–7 6.14 (0.662) 4.72 (0.371) 5.01 (0.403) 0.161
Urea (g/L),
n = 5–7 0.286 (0.0104) 0.148 (0.0198) 0.186 (0.0210)
<0.001 [(C versus F) <0.001;
(C versus FM) 0.001;
(F versus FM) 0.163]
Creatinine (mg/L),
n = 5–7 5.14 (0.153) 4.56 (0.108) 5.00 (0.162)
0.052 [(C versus F) 0.019;
(C versus FM) 0.492;
(F versus FM) 0.065]
Total proteins (g/L),
n = 5–7 59.57 (0.634) 62.98 (0.881) 61.49 (0.710)
0.018 [(C versus F) 0.006;
(C versus FM) 0.068;
(F versus FM) 0.182]
Albumin (g/L),
n = 5–7 27.23 (0.342) 29.50 (0.214) 29.01 (0.304)
<0.001 [(C versus F) <0.001;
(C versus FM) 0.001;
(F versus FM) 0.283]
Total cholesterol (g/L),
n = 5–7 0.686 (0.0334) 0.666 (0.100) 0.753 (0.0390) 0.525
HDL-cholesterol (g/L),
n = 5–7 0.357 (0.0224) 0.3540 (0.0486) 0.397 (0.0218) 0.518
LDL-cholesterol (g/L),
n = 5–7 0.201 (0.0126) 0.204 (0.0227) 0.229 (0.0201) 0.505
HDL-cholesterol/total
cholesterol,
n = 5–7
0.520 (0.0140) 0.536 (0.0104) 0.527 (0.00888) 0.637
HDL-cholesterol/LDL
cholesterol,
n = 5–7
1.82 (0.189) 1.75 (0.164) 1.81 (0.171) 0.963
Ferritin (U/L),
n = 5–7 24.33 (2.577) 19.18 (0.450) 19.63 (0.374)
0.082 [(C versus F) 0.055;
(C versus FM) 0.055;
(F versus FM) 0.859]
OPG (pg/mL),
n = 6-7 789.57 (226.538) 571.21 (40.265) 667.87 (83.676) 0.606
RANKL (pg/mL),
n = 6-7 10.15 (1.694) 13.91 (2.675) 7.79 (1.470) 0.143
OPG/RANKL,
n = 5–7 126.37 (57.324) 45.37 (9.376) 109.38 (41.657) 0.401
C-reactive protein
(mg/L),
n = 5-6
0.04167 (0.0095) 0.03800 (0.0058) 0.05500 (0.0034) 0.216
Substance P (pg/mL),
𝑛 = 7
1978.67 (184.475) 1968.55 (216.113) 2416.07 (158.299) 0.186
TNF-𝛼 (pg/mL),
𝑛 = 7
718.80 (121.457) 2282.75 (1142.161) 818.77 (241.407) 0.216
IL-6 (pg/mL),
n = 5-6 3.007 (0.412) 3.486 (0.601) 2.681 (0.363) 0.514
C or CONT: control; F or FRUCT: 10% fructose in tap water; FM or FRUCTMIN: 10% fructose in natural mineral-rich water; GOT: glutamic-oxaloacetic
transaminase; GPT: glutamic-pyruvic transaminase; IL-6: interleukin-6; OPG: osteoprotegerin; RANKL: receptor activator of nuclear factor kappa-B ligand;
SEM: standard error of the mean; TNF-𝛼: tumor necrosis factor-alpha.
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Figure 3: (a) Urine volume (mL/24 h; 𝑛 = 7; $𝑃 < 0.01 CONT versus FRUCT and 𝑃 < 0.05 CONT versus FRUCTMIN; #𝑃 < 0.01 CONT
versus FRUCT and FRUCTMIN), (b) urinary sodium excretion (mEq/24 h; 𝑛 = 6-7; ∗𝑃 < 0.01 FRUCTMIN versus CONT and 𝑃 < 0.05 for
FRUCTMIN versus FRUCT), and (c) urinary creatinine excretion evolution (mg/24 h; 𝑛 = 6-7), every other week during the first 6 weeks of
the dietary intervention. Results were expressed as mean ± standard error of the mean. CONT: control; FRUCT: 10% fructose in tap water;
FRUCTMIN: 10% fructose in natural mineral-rich water.
GSSG and a strong tendency for GSH/GSSG (𝑃 = 0.062,
global 𝑃 = 0.045)). Natural mineral-rich water ingestion
counteracted all these modifications. Regarding catalase and
GSSG, therewas a strong trend to, respectively, a decrease and
an increase in FRUCTMIN versus FRUCT (𝑃 = 0.065 and
𝑃 = 0.055, resp.). No significant modifications were observed
for 8-OHdG levels (data not shown) neither for other redox
parameters (Table 4).
3.6. LiverMagnesium andCalciumContent. A slight decrease
was observed in FRUCT versus CONT for both liver mag-
nesium and calcium content that was prevented by natural
International Journal of Endocrinology 9
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Figure 4: (a) Systolic blood pressure (mm Hg; 𝑛 = 4–7) and diastolic blood pressure (mm Hg; 𝑛 = 4–7), and (b) heart rate evolution
(beats/min; 𝑛 = 4–7; ∗𝑃 < 0.05 CONT versus FRUCT; ∗∗𝑃 < 0.01 CONT versus FRUCT), during the dietary intervention. Results were
expressed as mean ± standard error of the mean. CONT: control; FRUCT: 10% fructose in tap water; FRUCTMIN: 10% fructose in natural
mineral-rich water.
Table 3: Plasma electrolyte content, at the end of the dietary intervention.
CONT FRUCT FRUCTMIN Global P
[P between groups]Mean (SEM) Mean (SEM) Mean (SEM)
Sodium (mEq/L),
n = 5–7 142.42 (1.270) 143.60 (0.872) 144.57 (0.719) 0.318
Potassium (mEq/L),
n = 5–7 5.90 (0.236) 5.92 (0.208) 5.48 (0.150) 0.261
Chloride (mEq/L),
n = 5–7 100.00 (0.976) 99.60 (0.600) 100.29 (0.565) 0.836
Magnesium (mEq/L),
n = 5–7 1.71 (0.0513) 1.54 (0.0385) 1.55 (0.0431)
0.025
[(C versus F) 0.020;
(C versus FM) 0.017;
(F versus FM) 0.873]
Calcium (mEq/L),
n = 5–7 5.32 (0.0346) 5.44 (0.0600) 5.42 (0.0359) 0.124
Phosphorus (mg/L),
n = 5–7 76.11 (3.841) 76.62 (1.964) 79.30 (3.167) 0.756
C or CONT: control; F or FRUCT: 10% fructose in tap water; FM or FRUCTMIN: 10% fructose in natural mineral-rich water; SEM: standard error of the mean.
mineral-rich water ingestion (Figures 8(a) and 8(b), resp.),
most particularly for magnesium.
4. Discussion
The fructose-fed SDR model mimics a predominantly envi-
ronmentally acquired MS model [15] that is commonly used
in MS research. Similarly, in the present study, many of
the alterations observed in different protocols of fructose-
induced MS were recapitulated. Increased systolic BP, adi-
posity index and liver and kidney weight to body weight
ratios as well as modulation of the hepatic redox status and
similar changes in the plasma levels of hormones, except for
aldosterone, and/or energy substrates evaluated in this work
have been reported in different protocols of fructose-induced
MS in SDR [15–18, 20, 22–24, 36–38].
As previously reported [17], fructose intervention in-
creases SDR body weight, but besides fructose metabolic
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Figure 5: Organ weight to body weight ratios. (a) Liver (𝑛 = 7), (b) epididymal adipose tissue (𝑛 = 7), (c) right kidney (𝑛 = 6- 7), and (d)
left kidney (𝑛 = 6-7), at the end of the dietary intervention. Results were expressed as mean ± standard error of the mean. #𝑃 < 0.001 CONT
versus FRUCT, ##𝑃 < 0.005 FRUCT versus FRUCTMIN, and ∗𝑃 < 0.05 CONT versus FRUCT. AT: adipose tissue; CONT: control; FRUCT:
10% fructose in tap water; FRUCTMIN: 10% fructose in natural mineral-rich water; G𝑃: global P.
effects, two details of our experimental protocol could have
contributed to body weight increase: rats were housed indi-
vidually, which may have reduced their physical activity,
and were already adult rats at the beginning of the dietary
manipulation (their age was reflected in the high body
weight values 475–597 g), which may have amplified fruc-
tose metabolic effects [39]. Additionally to the variations
observed in food and fluid ingestions seen in the CONT
group with aging (over the 8 weeks of dietary intervention),
fructose-fed rats adjusted fluid and food ingestions, aiming
to maintain the level of energy consumption, as previously
described [18]. Fructose-fed animals increased their body
weight similarly between them and more than control rats
(associated with a small increase of epididymal body-fat),
reflecting the absence of anymajor naturalmineral-richwater
consumption effect on both food and fructose ingestions.
Accordingly, effects shown below against MS induction in
FRUCTMIN rats related exclusively to natural mineral-rich
water ingestion and, interestingly, natural mineral-rich water
ingestion reduced/prevented the majority of the fructose
effects and, consequently, protected against MS induction,
which, to our knowledge, is described here for the first
time. MS represents a risk for cardiovascular disease (whose
prevalence is increasing worldwide), which, together with the
recent report of Luo et al. on the consumption of low-mineral
bottledwater that increases the risk for cardiovascular disease
[40], demonstrates the high relevance of our research.
The significant increase in plasma insulin levels in the
FRUCT versus CONT group could have contributed to the
significant effects in systolic BP and HR described before
(the effect of natural mineral-rich water with time on HR
and diastolic BP decreased after body weight adjustment).
Hyperinsulinemia may increase BP and HR by increasing
the sympathetic nervous system activity, through alteration
in the neuronal vascular control and/or by enhancement of
kidney sodium reabsorption [6, 41, 42]. Increased sympa-
thetic modulation of vessels and heart precedes metabolic
dysfunction in mice drinking 10% fructose in tap water for
up to 2months [43]. HR, amarker of autonomic dysfunction,
associates with MS, particularly with insulin resistance, and
interestingly, in Japan, the prevalence ofMS increases linearly
with the increase in HR [1, 44].
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Figure 6: Metabolic markers and hormonal status in plasma. (a) Glucose (g/L; 𝑛 = 7), (b) triacylglycerols (g/L; 𝑛 = 5–7), (c) insulin (𝜇g/L;
𝑛 = 7), (d) leptin (pg/mL; 𝑛 = 6), (e) aldosterone (ng/mL; 𝑛 = 7), and (f) melatonin levels (pg/mL; 𝑛 = 6), at the end of the dietary
intervention. Results were expressed as mean ± standard error of the mean. ∗𝑃 < 0.05 CONT versus FRUCT. CONT: control; FRUCT: 10%
fructose in tap water; FRUCTMIN: 10% fructose in natural mineral-rich water; G𝑃: global P.
BP correlates with plasma aldosterone levels and an
association between plasma aldosterone levels and hyperin-
sulinemia has been described in obesity [45]. Although both
fructose-fed groups in the present study had significantly
increased body weight versus controls, the insulin value in
the FRUCTMIN group (that after body weight adjustment
presented a strong tendency to decrease versus FRUCT
(data not shown)), along with the later BP increase, was
in accordance with the unaltered aldosterone levels in the
FRUCTMIN group. In fructose-fed SDR, the absence of
a significant increase in body weight associates with no
increase of aldosterone levels, in spite of hyperinsulinemia
[46].
Leptin resistance may be an early feature of metabolic
dysfunction induced by fructose-feeding, since it may pre-
cede increased adiposity, elevated circulating leptin levels,
12 International Journal of Endocrinology
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Figure 7: Redox state markers in liver. (a) Catalase (U catalase/mg protein; 𝑛 = 7), (b) superoxide dismutase (U SOD/mg protein; 𝑛 = 7), (c)
glutathione peroxidase activities (U GPx/mg protein; 𝑛 = 7), (d) oxidized glutathione content (nmol/mg protein; 𝑛 = 7), (e) GSH to GSSG
ratio (𝑛 = 7), and (f) sirtuin 3 protein expression (arbitrary units (a.u.); 𝑛 = 5-6), at the end of the dietary intervention. Results were expressed
as mean ± standard error of the mean. ∗𝑃 < 0.05 CONT versus FRUCT; ∗∗∗𝑃 < 0.005 CONT versus FRUCT. CONT: control; FRUCT: 10%
fructose in tap water; FRUCTMIN: 10% fructose in natural mineral-rich water; G𝑃: global P; GPx: glutathione peroxidase; GSH: reduced
glutathione; GSSG: oxidized glutathione; Sirt3: sirtuin 3; SOD: superoxide dismutase.
and changes in glucose metabolism in rats. Despite higher
leptin levels (with the comparison versus CONT significant
after adjustment for body weight (data not shown)), which
would anticipate a reduction in food intake and body fat
in healthy conditions, FRUCT rats had a lower decrease of
food ingestion with time than FRUCTMIN rats (significant
after adjustment for body weight (data not shown)) as well
as a similar weight gain and amount of epididymal fat. These
results could reflect a phenomenon of selective leptin resis-
tance that, together with the activation of the sympathetic
International Journal of Endocrinology 13
CONT FRUCT FRUCTMIN
300
410
520
630
Li
ve
r M
g 
(𝜇
g/
g)
GP = 0.118
(a)
CONT FRUCT FRUCTMIN
0
25
50
75
100
Li
ve
r C
a (
𝜇
g/
g)
GP = 0.249
(b)
Figure 8: Liver magnesium (a) and calcium (b) content (𝜇g/g of tissue lyophilize; 𝑛 = 6 for both elements), at the end of the dietary
intervention. Results were expressed as mean ± standard error of the mean. Ca: calcium; CONT: control; FRUCT: 10% fructose in tap water;
FRUCTMIN: 10% fructose in natural mineral-rich water; G𝑃: global P; Mg: magnesium.
nerves by hyperleptinemia, could have contributed to the
earlier development of hypertension in FRUCT rats [5, 47–
49]. Melatonin has anti-inflammatory, antihyperlipidemic,
and antihypertensive properties and it is known to influence
insulin secretion and to enhance its action (it increases
insulin sensitivity and enhances insulin effects on leptin
expression) [19, 50–52]. The apparent deregulation of leptin,
melatonin, insulin, and aldosterone observed in the FRUCT
group, owing tomodifications in the hormone levels, was less
evident in the FRUCTMIN group.
Fructose is highly lipogenic as its hepatic metabolism
provides great amounts of triose phosphate precursors for
fatty acid synthesis [5, 6]. Reduced leptin and insulin sensi-
tivities contribute to hypertriglyceridemia induced by fruc-
tose ingestion [53]. The difference in triacylglycerol levels
in the two fructose-fed groups could be explained by the
improvement of leptin, insulin, and aldosterone levels in
FRUCTMIN induced by the natural mineral-rich water
ingestion (the magnitude of triacylglycerols increase versus
CONT was reduced after body weight adjustment (data not
shown)). Normalization of melatonin levels could have also
contributed [52, 54].
The increase in plasma albumin and total protein levels
has been described in fructose-fed rats [55], which could
reflect a combination of undernutrition (also because of the
decrease in food ingestion), some degree of liver disorder
(resulting fromMS induction), and/or dehydration (owing to
loose stools resulting from incomplete fructose absorption)
[56, 57]. Nevertheless, the pattern of urine volume mirrored
the pattern of fluid ingestion and we did not observe loose
stools, which makes dehydration unlikely in the fructose-fed
rats.
Although we found a significant increase in both kidneys
weight to body weight ratios in the FRUCT group, we be-
lieve that there was no renal functional alteration in this
SDR group taking into consideration the plasma and/or
urinary profiles of creatinine, urea, albumin, total proteins,
magnesium, sodium, potassium, calcium, chloride, andphos-
phorous. Despite an increase in the kidney weight to body
weight ratio, Rizkalla et al. reported no glomerular basement
membrane thickening in SDR after 10 weeks of 57% fructose-
feeding [36].
Fructose-feeding accelerates osteoporosis [58] and, ac-
cordingly, the OPG to RANKL ratio (reflecting the ratio of
osteoblast versus osteoclast activities [58, 59]) seemed to
decrease in the FRUCT group. Interestingly, and in accor-
dance with FRUCT group results, TNF-𝛼 and IL-6 are
important mediators in the process of osteoclast differenti-
ation and activation [59] and, thus, the changes observed
in their levels might have contributed to the lower OPG to
RANKL ratio. High levels of leptin and aldosterone have been
linked to proinflammatory and prooxidant actions [45, 47].
In the FRUCTMIN group, the improvement of the leptin,
aldosterone, TNF-𝛼, and IL-6 values could have contributed
to the improvement of the OPG to RANKL ratio.
Taking into consideration all the results obtained for
both fructose-fed SDR groups, the slightly increased levels of
substance P and CRP in FRUCTMIN rats were unexpected.
Plasma substance P levels increase under magnesium defi-
ciency and contribute to increase inflammation and protein
and lipid oxidation [60]. In fact, plasma magnesium levels
of both fructose groups were significantly decreased, but the
FRUCTMIN group displayed better plasma TNF-𝛼 and IL-6
levels as well as lower hepatic protein oxidation content (after
adjustment for body weight this latter parameter showed a
tendency to a decrease in FRUCTMIN versus the other two
groups, most particularly versus FRUCT (data not shown)).
Interestingly, high CRP levels occur in energy restricted
animals [61].
In FRUCT animals, the absence of oxidative lesions in
lipids, proteins, and DNA (the same as for proteins hap-
pened for DNA oxidative lesions (data not shown)) could
be explained by the significantly increased catalase activity
and apparently increased SOD activity. Polizio et al. describe
similar results for lipid oxidative lesions and catalase and
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Table 4: Hepatic redox state characterization, at the end of the dietary intervention.
CONT FRUCT FRUCTMIN Global P
Mean (SEM) Mean (SEM) Mean (SEM)
Glutathione-reductase
(UGR/mg protein),
𝑛 = 7
0.0297 (0.0015) 0.0320 (0.0011) 0.0322 (0.0022) 0.507
Glutathione-S-transferase
(UGST/mg protein),
𝑛 = 7
0.3754 (0.0261) 0.3738 (0.0319) 0.3764 (0.0263) 0.998
Reduced glutathione
(nmol/mg protein), 𝑛 = 7 360.5082 (16.4242) 332.0008 (9.0570) 309.9596 (29.5796) 0.235
Malondialdehyde (nmol/mg
protein), 𝑛 = 6 0.0108 (0.0010) 0.0100 (0.0012) 0.0121 (0.0013) 0.424
Protein carbonyls (nmol/mg
protein), 𝑛 = 7 0.8465 (0.0732) 0.9828 (0.0808) 0.7305 (0.0866) 0.113
CONT: control; FRUCT: 10% fructose in tap water; FRUCTMIN: 10% fructose in natural mineral-rich water; GR: glutathione-reductase; GST: glutathione-S-
transferase; SEM: standard error of the mean.
Metabolic Syndrome animal model
Sprague-Dawley rats with10% fructose in tap water,
for 8 weeks
Reduced the effects
Increased heart rate
Reduced the
effects
Sprague-Dawley rats with
10% fructose in a
hypersaline sodium-rich
naturally sparkling mineral
water, for 8 weeks
Increased:
organ weight to body weight ratios (for liver and both kidneys)
plasma triacylglycerols, insulin, and leptin levels
hepatic catalase activity
Decreased:
hepatic glutathione peroxidase activity
oxidized glutathione content
Figure 9: Summary of fructose-feeding effects that were reduced/prevented by the natural mineral-rich water.
SOD activities by 10% fructose ingestion in tap water [24].
The significant decrease in GPx activity in FRUCT rats
could be partially compensated by the significant increase in
catalase activity, since both enzymes can eliminate hydrogen
peroxide (converting it to water). Catalase is responsible for
the elimination of high concentrations of hydrogen peroxide,
while GPx does it when concentrations of hydrogen peroxide
are low [62]. The higher levels of hydrogen peroxide could
have resulted from the fructose-feeding [7, 63] and the small
decrease of Sirt3 protein expression could have intensified
reactive oxygen species production in FRUCT rats [64].
The significant decrease in hepatic GPx activity could have
contributed to the strong tendency for an increase in the
GSH/GSSG ratio in FRUCT versus CONT, by oxidizing
less GSH to GSSG. Increased GSSG efflux from hepatocytes
and/or increased hepatic GSH synthesis induced by fructose
could also apply. However, we did not observe an increase
in GSH level as it might have been expected from a lower
GSH oxidation and/or increased GSH synthesis. Although
cellular ATP depletion induced by fructose prevents ATP-
dependent GSSG efflux in freshly isolated rat hepatocytes
[65], this phenomenon should not have a strong impact
here since an increase in uric acid formation was not
observed. The variations observed for GPx, SOD, and cata-
lase activities in the two fructose-fed groups are in accor-
dance with the antioxidant actions of melatonin (probably
its primary function) and Sirt3. Melatonin possesses free
radical-scavenging activity, stimulates antioxidant enzymes
(e.g., GPx), and inhibits reactive oxygen/nitrogen species
producing enzymes [66, 67]. Sirt3 has beneficial effects on
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mitochondrial electron transport chain (contributing to a
reduction in the production of reactive oxygen species) and
mitochondrial antioxidant enzymes (probably also on GPx,
like melatonin) [64]. Reduction of Sirt3 associates with an
accelerated development of metabolic abnormalities similar
to the MS [68], which is in agreement with our overall
results.
Our results also showed that the natural mineral-rich
water could contribute to the preservation of the hepatic
intracellular ions, namely the magnesium content. It is well
documented that plasma ion levels might not reflect their
tissue levels, and here this was evident regarding plasma
and hepatic concentrations of magnesium and calcium.
Magnesium deficiency is associated with insulin resistance.
For quite some time, it was thought that it could be the cause
of insulin resistance, but very recently it was described that
type 2 Diabetes Mellitus and a lower degree of metabolic
control are essential in accounting for the lower levels of
serum magnesium that occur in obese individuals [69].
5. Conclusion
Figure 9 summarizes the significant effects of fructose-feed-
ing obtained in this research that were reduced/prevent-ed by
the naturalmineral-richwater (taking into consideration that
when fructose was coingested with the natural mineral-rich
water no significant effects were observed versus the control).
Still, although for some of the parameters evaluated in
our study the extension of differences among groups did
not achieve statistical significance, the variations observed
were consistent with the pattern expected, which reinforces
their biological relevance and justifies their presentation and
discussion.
The results here described suggest that this naturalminer-
al-rich water seems to have potential to prevent MS induc-
tion. We hypothesize that its regular intake in the context of
modern diets, which have a general acidic character interfer-
ingwithmineral homeostasis and are poor inmicronutrients,
namely potassium, calcium, and magnesium, could add
surplus value and attenuate imbalances, thus contributing to
metabolic and redox health and, consequently, decreasing the
risk for atherosclerotic cardiovascular disease.
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